共 50 条
- [33] Different Efficacy of Osimertinib for EGFR Exon 19del or L858R in NSCLC Patients with Brain Metastases INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E143 - E143
- [38] Are exon 19 deletions and L858R EGFR mutations in non-small-cell lung cancer clinically different? British Journal of Cancer, 2007, 96 : 399 - 399